Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-10-18
pubmed:abstractText
The aim of this study was to determine the uptake and disposition of inhaled 1,1,1,2-tetrafluoroethane (HFC-134a) in humans. Ten male volunteers were exposed to 500 ppm HFC-134a (2 h, 50 W exercise). The HFC-134a levels were monitored in blood, exhaled air and urine up to 19 h post-exposure. The concentration in blood increased rapidly, reaching a plateau of 9.4+/-1.9 microM (mean+/-S.D.) within 30 min, followed by a fast post-exposure decrease. HFC-134a in expired air decreased rapidly as well and in parallel with that in blood. The post-exposure urinary excretion was 0.002% of the inhaled amount, and the half-time was 58 min (pooled data). A physiologically based toxicokinetic (PBTK) model was developed for further analysis. Experimental and simulated time courses in blood and exhaled air agreed well in all 10 subjects. Further, the late decay in blood was consistent with a wash-out of HFC-134a from fat tissues, with a half-time of 114+/-21 min. The simulated relative uptake during exposure was 3.7+/-0.5%. No remarkable findings were observed in the electrocardiographic recordings. Fibrinogen in plasma increased 1 day after exposure, whereas no effects on C-reactive protein, serum amyloid A protein, D-dimer or uric acid were seen. Further studies are needed to investigate the possible inflammatory response.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0378-4274
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
167
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
54-65
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17030466-Adult, pubmed-meshheading:17030466-Algorithms, pubmed-meshheading:17030466-Arrhythmias, Cardiac, pubmed-meshheading:17030466-C-Reactive Protein, pubmed-meshheading:17030466-Central Nervous System, pubmed-meshheading:17030466-Clinical Trials as Topic, pubmed-meshheading:17030466-Electrocardiography, pubmed-meshheading:17030466-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:17030466-Fibrinogen, pubmed-meshheading:17030466-Heart Rate, pubmed-meshheading:17030466-Humans, pubmed-meshheading:17030466-Hydrocarbons, Fluorinated, pubmed-meshheading:17030466-Inhalation Exposure, pubmed-meshheading:17030466-Irritants, pubmed-meshheading:17030466-Male, pubmed-meshheading:17030466-Models, Statistical, pubmed-meshheading:17030466-Regional Blood Flow, pubmed-meshheading:17030466-Respiratory Mechanics, pubmed-meshheading:17030466-Serum Amyloid A Protein, pubmed-meshheading:17030466-Tissue Distribution, pubmed-meshheading:17030466-Uric Acid
pubmed:year
2006
pubmed:articleTitle
Toxicokinetics of 1,1,1,2-tetrafluoroethane (HFC-134a) in male volunteers after experimental exposure.
pubmed:affiliation
Work Environment Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. sara.gunnare@ki.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't